IRTCiRhythm Holdings, Inc.

$122.32

The financials

iRhythm Holdings, Inc. by the numbers

iRhythm Holdings, Inc. (IRTC) reported revenue of $224M in Q2 2026 (quarter ended Jun 30, 2026), up 20% from the same quarter a year earlier. That came with a gross margin of 73% and net loss of $381K. For the full year FY2025, revenue was $747M (+26% year on year) and net income −$45M. Its largest product in Q2 2026 was Commercial Payors at $114M, 51% of the disclosed total, well ahead of Centers For Medicare Medicaid Services at 26%.

iRhythm Holdings, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$224M$187M+20%
Gross profit$163M$133M+23%
Operating income−$2.5M−$19Mn/a
Net income−$381K−$14Mn/a
Diluted EPS−$0.01−$0.44n/a
Revenue by product, Q2 2026, as reported to the SEC
ProductRevenueShare
Commercial Payors$114M51%
Centers For Medicare Medicaid Services$59M26%
Healthcare Institutions$38M17%
Non Contracted Third Party Payors$14M6.3%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q2 2026Total $224.2M (+12%)
Centers For Medicare Medicaid Services grew +32% year on yearNon Contracted Third Party Payors +11% year on year
  • Commercial Payors$113.8MQoQ +6.5%year on year +16%
  • Centers For Medicare Medicaid Services$58.5MQoQ +14%year on year +32%
  • Healthcare Institutions$37.8MQoQ +25%year on year +19%
  • Non Contracted Third Party Payors$14.1MQoQ +27%year on year +11%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed 2026-08-06, SEC EDGAR